Related Experiment Videos
Three forms of dominant amyloid neuropathy
The Johns Hopkins Medical Journal
|December 1, 1981
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Understanding the hydrological and landscape connectivity of lakes.
Landscape ecology·2025
Using Real-world Data to Define a Validated Nomogram for Advanced Bladder Cancer Patients Who Respond to Immunotherapy.
Clinical oncology (Royal College of Radiologists (Great Britain))·2022
Measuring particle size distribution and mass concentration of nanoplastics and microplastics: addressing some analytical challenges in the sub-micron size range.
Journal of colloid and interface science·2021
Preliminary Laboratory Vibration Testing of a Complete Neonatal Patient Transport System.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2020
Effect of obesity, dyslipidemia, and diabetes on trastuzumab-related cardiotoxicity in breast cancer.
Current oncology (Toronto, Ont.)·2019
Presence of fungiform papillae in classic dysautonomia.
The Johns Hopkins medical journal·1982
True hermaphroditism.
The Johns Hopkins medical journal·1982
Fetal mortality associated with cleft lip and cleft palate.
The Johns Hopkins medical journal·1982
Antagonism of acute copper(II)-induced renal lesions by sodium 2,3-dimercaptopropanesulfonate.
The Johns Hopkins medical journal·1982
Health education for behavioral change--clinical trial to public health program.
The Johns Hopkins medical journal·1982
New directions in cancer control.
The Johns Hopkins medical journal·1982
Neuroprotection of engineered Clostridium butyricum-pMTL007-GLP-1 in A53T α-synuclein (α-syn) mouse model via PI3K/AKT/GSK-3β.
Journal of Zhejiang University. Science. B·2026
Incidence and clinical characteristics of amyotrophic lateral sclerosis during the post-COVID-19 Period: a population-based study from Isfahan, Iran.
Neurodegenerative disease management·2026